Evidence map›Paper›PMID 33261940›Full record

ArticleEuropean urology2021

Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36.

Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, Jamed W F Catto

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in European urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 61% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Valeria PanebiancoDepartment of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Policlinico Umberto I Hospital, Viale del Policlinico 155, 00161 Rome, Italy. Electronic address: valeria.panebianco@uniroma1.it.
Francesco Del GiudiceDepartment of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, Rome, Italy. Electronic address: francesco.delgiudice@uniroma1.it.
Yoshifumi NarumiDepartment of Healthcare, Tachibana University, Kyoto, Japan.
Giuseppe SimoneDepartment of Urology, Regina Elena National Cancer Institute, Rome, Italy.
Ettore De BerardinisDepartment of Maternal-Infant and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
Jamed W F CattoAcademic Urology Unit, University of Sheffield, Sheffield, UK.
Policlinico Umberto I · ITKyoto Tachibana University · JPUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Multiparametric Magnetic Resonance ImagingUrinary Bladder NeoplasmsAntibodies, Monoclonal, HumanizedHumansMusclesNeoadjuvant TherapyAntibodies, Monoclonal, Humanizedpembrolizumab

Identifiers

PMID33261940
OpenAlexW4255709241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.